Case Study 1

2.4% drop in HbA1c at 180 days—with patients averaging only 1.2 BGM readings per day—and 268 office visits avoided via remote monitoring

A 28-participant study at a family clinic in Los Angeles achieved an average HbA1c drop of 2.4% at 180 days, with patients averaging only 1.2 blood glucose meter readings per day. The clinic achieved these results using remote-monitoring meters that allowed the clinicians and their patients to avoid a combined total of 268 office visits.

Mayer B. Davidson, MD, Chief Medical Officer of Mellitus Health, presented findings of the study at the American Diabetes Association’s 78th Scientific Sessions on June 23 and June 25, 2018. Press release

Case Study 2

Lowering HbA1c values from an average of 11% to 7.2% in just one year

In the study, a nurse trained in insulin and non-insulin treatment algorithms managed patients in a low-income, minority community clinic in South Central Los Angeles. The 110 patients in the study had been on insulin and managed by the doctors for months or years with a very high rate of insulin failure.

Using our algorithms, the nurse stabilized this population, reducing its HbA1c from an average of 11.0% to an average of 7.2% HbA1c, a significant 3.8% drop.

The study by Dr. Davidson was published in the American Journal of Managed Care.

Case Study 3

Maintained a 7.7% average HbA1c, among the patients that are hardest to manage

At Los Angeles County diabetes clinics and the Venice Family Clinic, our chief medical officer, Dr. Mayer B. Davidson, treats patients who are disadvantaged in many ways that affect their health in general and their insulin management specifically.

While the U.S. average HbA1c for insulin-taking diabetics is 8.5%, in the 400–600 patients participating in this study the average HbA1c ranged from 7.5% to 7.7%—nearly a full point lower than the national average, despite their challenges.

“Accurate and rational decision making with respect to insulin dosages has always been a challenge for many clinicians who do not have extensive training and experience with today’s increasingly complex insulin regimens. Dr. Davidson's algorithms greatly simplify and streamline decision making for all insulin-treated diabetic patients, and effectively improve glycemic control.”

Stanley H. Hsia, MD FRCPC FACEAssociate Professor of Medicine Division of Endocrinology, Metabolism & Molecular MedicineCharles R. Drew University of Medicine and Science

“It’s easy to use, and it saves me time. I can see what the software recommends, and that gives me the confidence to help make dosing adjustments. Intensification of therapy is intimidating but necessary, and this tool helps me do it with precision, and with great results.”

Ligaya Scarlett, MSN, FNP-CFamily Nurse Practitioner at UCLA Health

Contact us to learn more

Schedule a Call